Cargando…

Transition from BOS to RAS impairs prognosis after lung transplantation—CLAD subtype analysis by CT volumetry

BACKGROUND: Chronic lung allograft dysfunction (CLAD), subclassified into bronchiolitis obliterans syndrome (BOS) or restrictive allograft syndrome (RAS), limits survival after lung transplantation. Information concerning transition from BOS to RAS is limited. We aimed to characterize the lung volum...

Descripción completa

Detalles Bibliográficos
Autores principales: Peräkylä, Laura, Nykänen, Antti, Piilonen, Anneli, Kesävuori, Risto, Halme, Maija, Raivio, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555659/
https://www.ncbi.nlm.nih.gov/pubmed/36223371
http://dx.doi.org/10.1371/journal.pone.0275563
_version_ 1784806908647964672
author Peräkylä, Laura
Nykänen, Antti
Piilonen, Anneli
Kesävuori, Risto
Halme, Maija
Raivio, Peter
author_facet Peräkylä, Laura
Nykänen, Antti
Piilonen, Anneli
Kesävuori, Risto
Halme, Maija
Raivio, Peter
author_sort Peräkylä, Laura
collection PubMed
description BACKGROUND: Chronic lung allograft dysfunction (CLAD), subclassified into bronchiolitis obliterans syndrome (BOS) or restrictive allograft syndrome (RAS), limits survival after lung transplantation. Information concerning transition from BOS to RAS is limited. We aimed to characterize the lung volume change after BOS diagnosis by computed tomography (CT) volumetry and to determine the incidence, risk factors and clinical significance of BOS to RAS transition. METHODS: CT volumetry measurements were performed from 63 patients with CLAD initially classified as BOS by CT volumetry. BOS patients with lung volume remaining >85% of baseline were classified as persistent BOS, whereas BOS patients whose lung volume permanently decreased to ≤85% of baseline were classified as BOS to RAS transition. RESULTS: During follow-up (median 9.8 years) eight patients (12.7%) were classified as BOS to RAS transition, which decreased recipient (p = 0.004) and graft survival (p = 0.020) in comparison to patients with persistent BOS. Opacities on chest imaging preceded BOS to RAS transition in 88% of patients. Opacities on chest imaging at BOS diagnosis and early CLAD diagnosis after transplantation were risk factors for transition. CONCLUSION: Based on lung volume decrease measured by CT volumetry, a small proportion of BOS patients transitioned to RAS which had an adverse effect on recipient and graft survival.
format Online
Article
Text
id pubmed-9555659
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-95556592022-10-13 Transition from BOS to RAS impairs prognosis after lung transplantation—CLAD subtype analysis by CT volumetry Peräkylä, Laura Nykänen, Antti Piilonen, Anneli Kesävuori, Risto Halme, Maija Raivio, Peter PLoS One Research Article BACKGROUND: Chronic lung allograft dysfunction (CLAD), subclassified into bronchiolitis obliterans syndrome (BOS) or restrictive allograft syndrome (RAS), limits survival after lung transplantation. Information concerning transition from BOS to RAS is limited. We aimed to characterize the lung volume change after BOS diagnosis by computed tomography (CT) volumetry and to determine the incidence, risk factors and clinical significance of BOS to RAS transition. METHODS: CT volumetry measurements were performed from 63 patients with CLAD initially classified as BOS by CT volumetry. BOS patients with lung volume remaining >85% of baseline were classified as persistent BOS, whereas BOS patients whose lung volume permanently decreased to ≤85% of baseline were classified as BOS to RAS transition. RESULTS: During follow-up (median 9.8 years) eight patients (12.7%) were classified as BOS to RAS transition, which decreased recipient (p = 0.004) and graft survival (p = 0.020) in comparison to patients with persistent BOS. Opacities on chest imaging preceded BOS to RAS transition in 88% of patients. Opacities on chest imaging at BOS diagnosis and early CLAD diagnosis after transplantation were risk factors for transition. CONCLUSION: Based on lung volume decrease measured by CT volumetry, a small proportion of BOS patients transitioned to RAS which had an adverse effect on recipient and graft survival. Public Library of Science 2022-10-12 /pmc/articles/PMC9555659/ /pubmed/36223371 http://dx.doi.org/10.1371/journal.pone.0275563 Text en © 2022 Peräkylä et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Peräkylä, Laura
Nykänen, Antti
Piilonen, Anneli
Kesävuori, Risto
Halme, Maija
Raivio, Peter
Transition from BOS to RAS impairs prognosis after lung transplantation—CLAD subtype analysis by CT volumetry
title Transition from BOS to RAS impairs prognosis after lung transplantation—CLAD subtype analysis by CT volumetry
title_full Transition from BOS to RAS impairs prognosis after lung transplantation—CLAD subtype analysis by CT volumetry
title_fullStr Transition from BOS to RAS impairs prognosis after lung transplantation—CLAD subtype analysis by CT volumetry
title_full_unstemmed Transition from BOS to RAS impairs prognosis after lung transplantation—CLAD subtype analysis by CT volumetry
title_short Transition from BOS to RAS impairs prognosis after lung transplantation—CLAD subtype analysis by CT volumetry
title_sort transition from bos to ras impairs prognosis after lung transplantation—clad subtype analysis by ct volumetry
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555659/
https://www.ncbi.nlm.nih.gov/pubmed/36223371
http://dx.doi.org/10.1371/journal.pone.0275563
work_keys_str_mv AT perakylalaura transitionfrombostorasimpairsprognosisafterlungtransplantationcladsubtypeanalysisbyctvolumetry
AT nykanenantti transitionfrombostorasimpairsprognosisafterlungtransplantationcladsubtypeanalysisbyctvolumetry
AT piilonenanneli transitionfrombostorasimpairsprognosisafterlungtransplantationcladsubtypeanalysisbyctvolumetry
AT kesavuoriristo transitionfrombostorasimpairsprognosisafterlungtransplantationcladsubtypeanalysisbyctvolumetry
AT halmemaija transitionfrombostorasimpairsprognosisafterlungtransplantationcladsubtypeanalysisbyctvolumetry
AT raiviopeter transitionfrombostorasimpairsprognosisafterlungtransplantationcladsubtypeanalysisbyctvolumetry